{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:32:24Z","timestamp":1791891144426,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"ABC Farmaceutici"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.pupt.2019.101851","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T19:33:59Z","timestamp":1569526439000},"page":"101851","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Comparison of anti-inflammatory mechanisms between doxofylline and theophylline in human monocytes"],"prefix":"10.1016","volume":"59","author":[{"given":"Maria","family":"Talmon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Massara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Brunini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigia Grazia","family":"Fresu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2019.101851_bib1","series-title":"Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Global Initiative for Chronic Obstructive Lung Disease","year":"2009"},{"key":"10.1016\/j.pupt.2019.101851_bib2","series-title":"Global Initiative for Asthma, Pocket Guide for Health Professionals","year":"2018"},{"key":"10.1016\/j.pupt.2019.101851_bib3","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/bmj.327.7416.643","article-title":"Methylxanthines for exacerbations of chronic obstructive pulmonary disease: meta-analysis of randomised trials","volume":"327","author":"Barr","year":"2003","journal-title":"Br. Med. J."},{"key":"10.1016\/j.pupt.2019.101851_bib4","first-page":"1681","article-title":"Doxofylline and theophylline: a comparative clinical study","volume":"6","author":"Faiz Akram","year":"2012","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.pupt.2019.101851_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pupt.2018.04.010","article-title":"Impact of doxofylline in COPD: a pairwise meta-analysis","volume":"51","author":"Cazzola M","year":"2018","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.pupt.2019.101851_bib6","article-title":"Efficacy and safety profile of doxofylline compared to theophylline in asthma: a meta-analysis","volume":"3","author":"Rosigliani","year":"2019","journal-title":"Multidiscip Respir Med"},{"key":"10.1016\/j.pupt.2019.101851_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/164_2016_71","article-title":"Xanthines and phosphodiesterase inhibitors","volume":"237","author":"Spina","year":"2017","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.pupt.2019.101851_bib8","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1517\/14656560903200667","article-title":"Doxofylline: a promising methylxanthine derivative for the treatment of asthma and chronic obstructive pulmonary disease","volume":"10","author":"Shukla","year":"2009","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.pupt.2019.101851_bib9","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.2147\/COPD.S150887","article-title":"Doxofylline is not just another theophylline!","volume":"12","author":"Matera","year":"2017","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.pupt.2019.101851_bib10","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1084\/jem.20040416","article-title":"Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages","volume":"200","author":"Cosio","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.pupt.2019.101851_bib11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1164\/rccm.200305-659OC","article-title":"Histone acetylase and deacetylase activity in alveolar macrophages and blood monocytes in asthma","volume":"170","author":"Cosio","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2019.101851_bib12","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1034\/j.1398-9995.2001.00097.x","article-title":"Low-dose theophylline does not exert its anti-inflammatory effects in mild asthma through upregulation of interleukin-10 in alveolar macrophages","volume":"56","author":"Oliver","year":"2001","journal-title":"Allergy"},{"key":"10.1016\/j.pupt.2019.101851_bib13","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.immuni.2012.10.016","article-title":"Conventional and monocyte-derived CD11b(+) dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen","volume":"38","author":"Plantinga","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.pupt.2019.101851_bib14","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.4049\/jimmunol.0900695","article-title":"Interactions between innate antiviral and atopic immunoinflammatory pathways precipitate and sustain asthma exacerbations in children","volume":"183","author":"Subrata","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.pupt.2019.101851_bib15","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1111\/cea.13265","article-title":"Monocytes accumulate in the airways of children with fatal asthma","volume":"48","author":"Eguiluz-Gracia","year":"2018","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.pupt.2019.101851_bib16","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3389\/fimmu.2015.00423","article-title":"Blood monocytes and their subsets: established features and open questions","volume":"6","author":"Ziegler-Heitbrock","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.pupt.2019.101851_bib17","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1182\/blood-2010-02-258558","article-title":"Nomenclature of monocytes and dendritic cells in blood","volume":"116","author":"Ziegler-Heitbrock","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.pupt.2019.101851_bib18","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.clim.2008.09.011","article-title":"Enhanced frequencies of CD14++CD16+, but not CD14+CD16+, peripheral blood monocytes in severe asthmatic patients","volume":"130","author":"Moniuszko","year":"2009","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.pupt.2019.101851_bib19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/bph.14074","article-title":"Vortioxetine exerts anti-inflammatory and immunomodulatory effects on human monocytes\/macrophages","volume":"175","author":"Talmon","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pupt.2019.101851_bib20","doi-asserted-by":"crossref","first-page":"34e39","DOI":"10.1016\/j.pupt.2017.04.006","article-title":"Doxofylline does not increase formoterol-induced cAMP nor MKP-1 expression in ASM cells resulting in lack of anti-inflammatory effect","volume":"45","author":"Patel","year":"2017","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.pupt.2019.101851_bib21","doi-asserted-by":"crossref","first-page":"55e61","DOI":"10.1016\/j.pupt.2011.10.007","article-title":"The mechanism of action of doxofylline is unrelated to HDAC inhibition, PDE inhibition or adenosine receptor antagonism","volume":"25","author":"van Mastbergen","year":"2012","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.pupt.2019.101851_bib22","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000059403","article-title":"Theophylline inhibits NF-kappaB activation in human peripheral blood mononuclear cells","volume":"128","author":"Umeda","year":"2002","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"Suppl 5","key":"10.1016\/j.pupt.2019.101851_bib23","first-page":"95","article-title":"Teophylline inhibits free oxygen radical production by human monocytes via phosphodiesterase inhibition","volume":"58","author":"Chorostowska-Wynimko","year":"2007","journal-title":"J. Physiol. Pharmacol."},{"issue":"164","key":"10.1016\/j.pupt.2019.101851_bib24","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ejmech.2018.12.061","article-title":"Identification of a novel DGK\u03b1 inhibitor for XLP-1 therapy by virtual screening","volume":"15","author":"Velnati","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"780","key":"10.1016\/j.pupt.2019.101851_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejphar.2016.03.028","article-title":"Modulation of human monocyte\/macrophage activity by tocilizumab, abatacept and etanercept: an in vitro study","volume":"5","author":"Obeng","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.pupt.2019.101851_bib26","first-page":"85","article-title":"Statistical analysis of real-time PCR data","volume":"22","author":"Yuan","year":"2006","journal-title":"Bioinformatics"},{"key":"10.1016\/j.pupt.2019.101851_bib27","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.4049\/jimmunol.135.5.3411","article-title":"Redistribution of protein kinase C activity in human 13 monocytes: correlation with activation of the respiratory burst","volume":"135","author":"Myers","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/j.pupt.2019.101851_bib28","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S1286-4579(02)01612-X","article-title":"Structural and functional analyses of bacterial lipopolysaccharides","volume":"4","author":"Caroff","year":"2002","journal-title":"Microb. Infect."},{"key":"10.1016\/j.pupt.2019.101851_bib29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S1081-1206(10)63476-X","article-title":"Anti-inflammatory effects of theophylline: modulation of cytokine production","volume":"77","author":"Mascali","year":"1996","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"10","key":"10.1016\/j.pupt.2019.101851_bib30","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/tra.12310","article-title":"Mechanisms regulating protein localization","volume":"16","author":"Bauer","year":"2015","journal-title":"Traffic"},{"key":"10.1016\/j.pupt.2019.101851_bib31","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1164\/rccm.201302-0388PP","volume":"188","author":"Barnes","year":"2013","journal-title":"Theophylline. Am J Respir Crit Care Med."},{"key":"10.1016\/j.pupt.2019.101851_bib32","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0140-6736(94)90127-9","article-title":"Anti-inflammatory effects of low-dose oral theophylline in atopic asthma","volume":"343","author":"Sullivan","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2019.101851_bib33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1084\/jem.20101387","article-title":"Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon","volume":"209","author":"Rivollier","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.pupt.2019.101851_bib34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/ni.3052","article-title":"The development and function of lung\u2010resident macrophages and dendritic cells","volume":"16","author":"Kopf","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.pupt.2019.101851_bib35","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physrev.00044.2005","article-title":"The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology","volume":"87","author":"Bedard","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.pupt.2019.101851_bib36","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2174\/1381612043452866","article-title":"The role of ROS and RNS in regulating Life and death of blood monocytes","volume":"10","author":"Baran","year":"2004","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.pupt.2019.101851_bib37","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1183\/09031936.94.07091585","article-title":"Enhancement of reactive oxygen species formation in stable and unstable asthmatic patients","volume":"7","author":"Vachier","year":"1994","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2019.101851_bib38","doi-asserted-by":"crossref","first-page":"231e234","DOI":"10.1016\/j.pupt.2010.04.002","article-title":"Doxofylline: a \u201cnovofylline\u201d","volume":"23","author":"Page","year":"2010","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.pupt.2019.101851_bib39","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.4049\/jimmunol.164.4.2028","article-title":"Lipopolysaccharide induces actin reorganization and tyrosine phosphorylation of Pyk2 and paxillin in monocytes and macrophages","volume":"164","author":"Williams","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.pupt.2019.101851_bib40","doi-asserted-by":"crossref","first-page":"16790","DOI":"10.1074\/jbc.M114.549717","article-title":"Misregulation of mammalian target of rapamycin (mTOR) complexes induced by albuminuria in proximal tubules","volume":"289","author":"Peruchetti","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pupt.2019.101851_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2018.00067","article-title":"LPS induces mTORC1 and mTORC2 activation during monocyte adhesion","volume":"5","author":"Ribeiro","year":"2018","journal-title":"Frontiers in Molecular Biosciences"},{"key":"10.1016\/j.pupt.2019.101851_bib42","article-title":"PKC-dependent human monocyte adhesion requires AMPK and Syk activation","volume":"7","author":"Chang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pupt.2019.101851_bib43","doi-asserted-by":"crossref","first-page":"8921","DOI":"10.1073\/pnas.132556899","article-title":"A molecular mechanism of action of theophylline: induction of histone deacetylase activity to decrease inflammatory gene expression","volume":"99","author":"Ito","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pupt.2019.101851_bib44","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa041892","article-title":"Decreased histone deacetylase activity in chronic obstructive pulmonary disease","volume":"352","author":"Ito","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pupt.2019.101851_bib45","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1164\/rccm.200906-0937OC","article-title":"Targeting phosphoinositide-3-kinase-d with theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease","volume":"182","author":"To","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2019.101851_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pupt.2017.10.008","article-title":"Steroid sparing effects of doxofylline","volume":"48","author":"Riffo-vasquez","year":"2018","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.pupt.2019.101851_bib47","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.pupt.2014.01.001","article-title":"Doxofylline, a novofylline inhibits lung inflammation induced by lipopolysacharide in the mouse","volume":"27","author":"Riffo-vasquez","year":"2014","journal-title":"Pulm. Pharmacol. Ther."}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553919301154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553919301154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:28:42Z","timestamp":1761082122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553919301154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":47,"alternative-id":["S1094553919301154"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2019.101851","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of anti-inflammatory mechanisms between doxofylline and theophylline in human monocytes","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2019.101851","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101851"}}